Drug recall · July 24, 2019
Fluorouracil Injection recall
Why: Presence of Particulate Matter; glass particulates
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi, Lake Zurich, IL 60047. 63323-117-61 [Fresenius Kabi brand] and NDC 63323-117-69 [NOVAPLUS brand]
- Lots / codes
Lot 6120420 NDC 63323-117-61, Product Code 101761 and Lot 6120341 NDC 63323-117-69, Product Code NP101761
- Quantity
- 14,016 vials
- Company
- Fresenius Kabi USA, LLC, Melrose Park, IL
- Distribution
- Nationwide USA and Puerto Rico
- Initiated
- June 28, 2019 · Voluntary: Firm initiated
- Classified
- July 17, 2019
- Reported
- July 24, 2019
- Ended
- September 20, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fluorouracil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.